OxfordOxford Mon - Fri 09:00-17:00 +44(0)1865-600222
LibPubMedia1@gmail.com
OxfordOxford Mon - Fri 09:00-17:00 +44(0)1865-600222
LibPubMedia1@gmail.com
J Venom Res
Open-access
Aptamers
Open-access
Aptamers 2019
03-04 April 2019, Oxford
Submit a manuscript

Speakers & Agenda

page under construction…please visit again…thank you..

Confirmed Speakers:

Professor Dr Witold FilipowiczEmeritus Faculty, The Friedrich Miescher Institute for Biomedical Sciences, Switzerland

Dr Mark BehlkeChief Scientific Officer, Integrated DNA Technologies, USA

Professor Dr Nikolaus Rajewsky, Max Delbrück Center for Molecular Medicine, Germany

Dr Erik MiskaCancer Research UK Senior Research Fellow, and member of the Biochemistry Department, Gurdon Institute, University of Cambridge, UK

Dr Laura Sepp-Lorenzino, Executive Director and Department Head, RNA Therapeutics Discovery Biology,
Merck Research Laboratories, PA, USA

Dr Ramesh PillaiGroup Leader, EMBL Grenoble, France

Professor Raymond SchiffelersAssociate Professor, UMC Utrecht, The Netherlands (Intra-venous delivery of microRNAs)

Dr Vittorio de Franciscis, Istituto per l’Endocrinologia e l’Oncologia Sperimentale del CNR “G. Salvatore”, Naples, Italy (Aptamer-miRNA/anti-miRNA conjugates for targeted cancer therapy)

Dr Eulalia Marti, Center for Genomic Regulation, Barcelona, Spain (Small non-coding RNAs deregulation: a pathogenic mechanism in Parkinson’s disease)

Professor Tamas Dalmay, Professor of RNA Biology, University of East Anglia, UK

Dr Martin Bushell, MRC Senior Research Fellow, MRC Toxicology Unit, Leicester, UK

Professor Costanza Emanueli, British Heart Foundation Senior Research Fellow, School of Clinical Sciences-Regenerative Medicine Bristol Royal Infirmary, UK

Professor Andrew Baker, British Heart Foundation Professor of Translational Cardiovascular Sciences and Deputy Director, Institute of Cardiovascular and Medical Sciences, University of Glasgow, UK

Professor Dr Gunter Meister, University of Regensburg, Germany

Dr David Young, University of Newcastle, UK (Non-coding RNAs in condrogenesis)

Dr Dmitry SamarskyEVP, Technology & Business Development, RiboBio, PR China

Professor Dr Georg SczakielProfessor and Director, Institute of Molecular Medicine, University of Luebeck, Germany

Dr Susana ObadDrug Discovery Manager, Santaris Pharma, Denmark

Professor Andrew Miller, Institute of Pharmaceutical Science, King’s College London, UK

Dr Tobias Poehlmann, Friedrich-Schiller-Universität Jena, Germany (Development of siRNA targetting approaches)

Dr Glen Ried, University of Sydney, Australia (Inhibition of mesothelioma tumour growth using microRNA mimics)